Keywords
Curation
Ncbi
Racine
Curation
Checkpoint
Ncbi
Racine
Ncbi
Exploration
Accueil
Racine
Racine

Serveur d'exploration sur les pandémies grippales - Curation (Ncbi)

Index « Keywords » - entrée « Vaccination (adverse effects) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Vaccination < Vaccination (adverse effects) < Vaccination (economics)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 10.
Ident.Authors (with country if any)Title
001147 (2011) Nick Andrews [Royaume-Uni] ; Julia Stowe ; Rustam Al-Shahi Salman ; Elizabeth MillerGuillain-Barré syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: self-controlled case series.
001186 (2011) Tessa M. Van'T Klooster [Pays-Bas] ; Jeanet M. Kemmeren ; Hester E. De Melker ; Patricia E. Vermeer-De Bondt ; Nicoline A T. Van Der MaasTwo doses of pandemic influenza A(H1N1) vaccine: tolerability in healthy young children in the Netherlands.
001620 (2013) Delia Bethell [Thaïlande] ; David Saunders [Thaïlande] ; Anan Jongkaewwattana [Thaïlande] ; Jarin Kramyu [Thaïlande] ; Arunee Thitithayanont [Thaïlande] ; Suwimon Wiboon-Ut [Thaïlande] ; Kosol Yongvanitchit [Thaïlande] ; Amporn Limsalakpetch [Thaïlande] ; Utaiwan Kum-Arb [Thaïlande] ; Nichapat Uthaimongkol [Thaïlande] ; Jean Michel Garcia [République populaire de Chine] ; Ans E. Timmermans [Thaïlande] ; Malik Peiris [République populaire de Chine] ; Stephen Thomas [Thaïlande] ; Anneke Engering [Thaïlande] ; Richard G. Jarman [Thaïlande] ; Duangrat Mongkolsirichaikul [Thaïlande] ; Carl Mason [Thaïlande] ; Nuanpan Khemnu [Thaïlande] ; Stuart D. Tyner [Thaïlande] ; Mark M. Fukuda [Thaïlande] ; Douglas S. Walsh [Thaïlande] ; Sathit Pichyangkul [Thaïlande]Evaluation of In Vitro Cross-Reactivity to Avian H5N1 and Pandemic H1N1 2009 Influenza Following Prime Boost Regimens of Seasonal Influenza Vaccination in Healthy Human Subjects: A Randomised Trial
001797 (2014) Alexander Lind [Suède] ; Anita Ramelius [Suède] ; Tomas Olsson [Suède] ; Lisen Arnheim-Dahlström [Suède] ; Favelle Lamb [Suède] ; Mohsen Khademi [Suède] ; Aditya Ambati [Suède] ; Markus Maeurer [Suède] ; Anna-Lena Nilsson [Suède] ; Izaura Lima Bomfim [Suède] ; Katharina Fink [Suède] ; Ke Lernmark [Suède]A/H1N1 antibodies and TRIB2 autoantibodies in narcolepsy patients diagnosed in conjunction with the Pandemrix vaccination campaign in Sweden 2009-2010.
001859 (2014) Christopher C. Blyth [Australie] ; Peter C. Richmond [Australie] ; Peter Jacoby [Australie] ; Patrick Thornton [Australie] ; Annette Regan [Australie] ; Christine Robins [Australie] ; Heath Kelly [Australie] ; David W. Smith [Australie] ; Paul V. Effler [Australie]The impact of pandemic A(H1N1)pdm09 influenza and vaccine-associated adverse events on parental attitudes and influenza vaccine uptake in young children.
001953 (2014) Sharon E. Frey ; David I. Bernstein ; Rebecca C. Brady ; Wendy A. Keitel ; Hana El Sahly ; Nadine Georges Rouphael ; Mark J. Mulligan ; Robert L. Atmar ; Srilatha Edupuganti ; Shital M. Patel ; Michelle Dickey ; Irene Graham ; Edwin L. Anderson ; Diana L. Noah ; Heather Hill ; Mark Wolff ; Robert B. BelshePhase II Trial in Adults of Concurrent or Sequential 2009 Pandemic H1N1 and 2009-2010 Seasonal Trivalent Influenza Vaccinations
001A35 (2016) Sara Ghaderi [Norvège] ; Nina Gunnes [Norvège] ; Inger Johanne Bakken [Norvège] ; Per Magnus [Norvège] ; Lill Trogstad [Norvège] ; Siri Eldevik H Berg [Norvège]Risk of Guillain-Barré syndrome after exposure to pandemic influenza A(H1N1)pdm09 vaccination or infection: a Norwegian population-based cohort study.
001A41 (2015) Timo Vesikari [États-Unis] ; Jan Hendrik Richardus ; Johan Berglund ; Tiina Korhonen ; Carl-Erik Flodmark ; Ann Lindstrand ; Sven Arne Silfverdal ; Vinod Bambure ; Adrian Caplanusi ; Ilse Dieussaert ; Sumita Roy-Ghanta ; David W. VaughnImmunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine in Children 6 Months to 17 Years of Age, Previously Vaccinated with an AS03-Adjuvanted A(H1N1)Pdm09 Vaccine: Two Open-label, Randomized Trials.
001B61 (????) S Sohail Ahmed ; Emanuele Montomoli ; Franco Laghi Pasini ; Lawrence SteinmanThe Safety of Adjuvanted Vaccines Revisited: Vaccine-Induced Narcolepsy.
001F55 (2019) Fredrik Granath [Suède] ; Rolf Gedeborg [Suède] ; Hans Smedje [Suède] ; Nils Feltelius [Suède]Change in risk for narcolepsy over time and impact of definition of onset date following vaccination with AS03 adjuvanted pandemic A/H1N1 influenza vaccine (Pandemrix) during the 2009 H1N1 influenza pandemic.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Ncbi/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Vaccination (adverse effects)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Vaccination (adverse effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Vaccination (adverse effects)
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021